The pharmaceutical industry in 2024 faced a relatively quiet year, with deal volumes similar to 2023 but lower deal values, ...

Failed to fetch dynamically imported module: https://finance.yahoo.com/assets/_app/immutable/nodes/95.C_N2kNfW.js ...

Both companies are longtime leaders in the pharmaceutical industry and have been making breakthroughs and delivering ...

Dipan Mehta of Elixir Equities notes that the Trump presidency and earnings season will be major market trends in 2025.

The Nifty50 index has now entered its second week of consolidation, and current indicators suggest that this trend is likely ...

Acadia’s 50-day moving average is in the process of crossing above the stock’s 200-day moving average. This crossover forms a ...

Sumeet Bagadia, Executive Director at Choice Broking has recommended M&M, Sun Pharma, and Dalmia Bharat as the top three ...

They set a “sector outperform” rating and a $18.00 price target on the stock. Chardan Capital lifted their price target on ...

NRx Pharmaceuticals shares gained after the company said it would buy California psychiatry clinic Kadima Neuropsychiatry Institute. The stock rose Thursday to $2.92, reaching a six-month high. Shares ...

Immedica Pharma AB, a global rare disease company will acquire Marinus Pharmaceuticals (NASDAQ:MRNS) by means of a tender ...

We recently compiled a list of the 13 Best Pharma Dividend Stocks To Buy In 2024. In this article, we are going to take a ...

We recently compiled a list of the 13 Best Pharma Dividend Stocks To Buy In 2024. In this article, we are going to take a ...